{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:26:36Z","timestamp":1793550396519,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41372-019-0566-8","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T13:02:44Z","timestamp":1578315764000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000\u20132015"],"prefix":"10.1038","volume":"40","author":[{"given":"Mette Line","family":"Donneborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Moelholm","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille Kure","family":"Vandborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Rodrigo-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Ebbesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"566_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297\u2013316.","journal-title":"Pediatrics"},{"key":"566_CR2","doi-asserted-by":"crossref","unstructured":"Volpe J Bilirubin and Brain Injury. Neurology of the Newborn. 5. Edition ed. Philadelphia: Saunders Elsevier; 2008. p. 619\u201351.","DOI":"10.1016\/B978-1-4160-3995-2.10013-5"},{"key":"566_CR3","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1651-2227.2009.01409.x","volume":"98","author":"TW Hansen","year":"2009","unstructured":"Hansen TW, Nietsch L, Norman E, Bjerre JV, Hascoet JM, Mreihil K, et al. Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr. 2009;98:1689\u201394.","journal-title":"Acta Paediatr"},{"key":"566_CR4","first-page":"199","volume":"13","author":"J Le Pichon","year":"2017","unstructured":"Le Pichon J, Riordan S, Watchko J, Shapiro S. The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr Pediatr Rev. 2017;13:199\u2013209.","journal-title":"Curr Pediatr Rev"},{"key":"566_CR5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1542\/peds.2013-1764","volume":"134","author":"I Iskander","year":"2014","unstructured":"Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, et al. Serum bilirubin and bilirubin\/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics. 2014;134:1330\u20139.","journal-title":"Pediatrics"},{"key":"566_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/adc.2006.105361","volume":"92","author":"D Manning","year":"2007","unstructured":"Manning D, Todd P, Maxwell M, Jane Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child. 2007;92:342\u20136.","journal-title":"Arch Dis Child"},{"key":"566_CR7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/jp.2010.137","volume":"31","author":"M Sgro","year":"2011","unstructured":"Sgro M, Campbell D, Barozzino T, Shah V. Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinatol. 2011;31:392\u20136.","journal-title":"J Perinatol"},{"key":"566_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0031-1274506","volume":"28","author":"Y Weng","year":"2011","unstructured":"Weng Y, Chiu Y, Cheng S, Hsieh M. Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20\u2009mg\/dL or more. Am J Perinatol. 2011;28:405\u201312.","journal-title":"Am J Perinatol"},{"key":"566_CR9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1651-2227.2011.02565.x","volume":"101","author":"F Ebbesen","year":"2012","unstructured":"Ebbesen F, Bjerre JV, Vandborg PK. Relation between serum bilirubin levels \u2265450 \u00b5mol\/L and bilirubin encephalopathy; a Danish population-based study. Acta Paediatr. 2012;101:384\u20139.","journal-title":"Acta Paediatr"},{"key":"566_CR10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1651-2227.2001.tb01368.x","volume":"89","author":"F Ebbesen","year":"2000","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213\u20137.","journal-title":"Acta Paediatr"},{"key":"566_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08035250410022170","volume":"94","author":"F Ebbesen","year":"2005","unstructured":"Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR, et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr. 2005;94:59\u201364.","journal-title":"Acta Paediatr"},{"key":"566_CR12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1651-2227.2008.00879.x","volume":"97","author":"JV Bjerre","year":"2008","unstructured":"Bjerre JV, Petersen JR, Ebbesen F. Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr. 2008;97:1030\u20134.","journal-title":"Acta Paediatr"},{"key":"566_CR13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/dmcn.12603","volume":"57","author":"PK Vandborg","year":"2015","unstructured":"Vandborg PK, Hansen BM, Greisen G, Mathiasen R, Kasper F, Ebbesen F. Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study. Dev Med Child Neurol. 2015;57:378\u201384.","journal-title":"Dev Med Child Neurol"},{"key":"566_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1542\/peds.2011-2760","volume":"130","author":"PK Vandborg","year":"2012","unstructured":"Vandborg PK, Hansen BM, Greisen G, Jepsen M, Ebbesen F. Follow-up of neonates with total serum bilirubin levels \u226525\u2009mg\/dL: a Danish population-based study. Pediatrics. 2012;130:61\u20136.","journal-title":"Pediatrics"},{"key":"566_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-199208000-00030","volume":"15","author":"P Rosenthal","year":"1992","unstructured":"Rosenthal P. Direct bilirubin measurements in term newborns-a waste of time and money? J Pediatr Gastroenterol Nutr. 1992;15:220\u20131.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"566_CR16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1542\/peds.112.6.1256","volume":"112","author":"P Govaert","year":"2003","unstructured":"Govaert P, Lequin M, Swarte R, Robben S, De Coo R, Weisglas-Kuperus N, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics. 2003;112:1256\u201363.","journal-title":"Pediatrics"},{"key":"566_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1542\/peds.110.1.127","volume":"110","author":"M Herschel","year":"2002","unstructured":"Herschel M, Karrison T, Wen M, Caldarelli L, Baron B. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics. 2002;110:127\u201330.","journal-title":"Pediatrics"},{"key":"566_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpeds.2015.12.067","volume":"171","author":"M Sgro","year":"2016","unstructured":"Sgro M, Kandasamy S, Shah V, Ofner M, Campbell D. Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines. J Pediatr. 2016;171:43\u20137.","journal-title":"J Pediatr"},{"key":"566_CR19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpeds.2015.08.048","volume":"168","author":"A McGillivray","year":"2016","unstructured":"McGillivray A, Polverino J, Badawi N, Evans N. Prospective surveillance of extreme neonatal hyperbilirubinemia in Australia. J Pediatr. 2016;168:82\u20137.","journal-title":"J Pediatr"},{"key":"566_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000351274","volume":"104","author":"MJ Gotink","year":"2013","unstructured":"Gotink MJ, Benders MJ, Lavrijsen SW, Rodrigues Pereira R, Hulzebos CV, Dijk PH. Severe neonatal hyperbilirubinemia in the Netherlands. Neonatology. 2013;104:137\u201342.","journal-title":"Neonatology"},{"key":"566_CR21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/jp.2016.106","volume":"36","author":"VK Bhutani","year":"2016","unstructured":"Bhutani VK, Meng NF, Knauer Y, Danielsen BH, Wong RJ, Stevenson DK, et al. Extreme hyperbilirubinemia and rescue exchange transfusion in California from 2007 to 2012. J Perinatol. 2016;36:853\u20137.","journal-title":"J Perinatol"},{"key":"566_CR22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/adc.2010.197616","volume":"96","author":"S Zoubir","year":"2011","unstructured":"Zoubir S, Mieth R, Berrut S, Roth-Kleiner M. Swiss Paediatric SU. Incidence of severe hyperbilirubinaemia in Switzerland: a nationwide population-based prospective study. Arch Dis Child. 2011;96:310\u20131.","journal-title":"Arch Dis Child"},{"key":"566_CR23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1542\/peds.2012-0253","volume":"130","author":"M Sgro","year":"2012","unstructured":"Sgro M, Campbell D, Kandasamy S, Shah V. Incidence of chronic bilirubin encephalopathy in Canada, 2007\u20132008. Pediatrics. 2012;130:886\u201390.","journal-title":"Pediatrics"},{"key":"566_CR24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1542\/peds.2014-0987","volume":"134","author":"M Kuzniewicz","year":"2014","unstructured":"Kuzniewicz M, Wickremasinghe A, Wu Y, McCulloch C, Walsh E, Wi S, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134:504\u20139.","journal-title":"Pediatrics"},{"key":"566_CR25","doi-asserted-by":"crossref","unstructured":"Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)\u2014Summary. Paediatr Child Health. 2007;12:401\u20137.","DOI":"10.1093\/pch\/12.5.401"},{"key":"566_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/jp.2008.20","volume":"28","author":"M Kaplan","year":"2008","unstructured":"Kaplan M, Merlob P, Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol. 2008;28:389\u201397.","journal-title":"J Perinatol"},{"key":"566_CR27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1542\/peds.2009-1412","volume":"125","author":"M Mah","year":"2010","unstructured":"Mah M, Clark S, Akhigbe E, Englebright J, Frye D, Meyers J, et al. Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening. Pediatrics. 2010;125:1143\u20138.","journal-title":"Pediatrics"},{"key":"566_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1542\/peds.2005-1338","volume":"117","author":"L Eggert","year":"2006","unstructured":"Eggert L, Wiedmeier S, Wilson J, Christensen R. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:855\u201362.","journal-title":"Pediatrics"},{"key":"566_CR29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1542\/peds.2008-2980","volume":"124","author":"MW Kuzniewicz","year":"2009","unstructured":"Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124:1031\u20139.","journal-title":"Pediatrics"},{"key":"566_CR30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0009922810363728","volume":"49","author":"A Alkalay","year":"2010","unstructured":"Alkalay A, Bresee C, Simmons C. Decreased neonatal jaundice readmission rate after implementing hyperbilirubinemia guidelines and universal screening for bilirubin. Clin Pediatr. 2010;49:830\u20133.","journal-title":"Clin Pediatr"},{"issue":"Suppl 1","key":"566_CR31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/jp.2008.216","volume":"29","author":"M Kaplan","year":"2009","unstructured":"Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol. 2009;29 Suppl 1:46\u201352.","journal-title":"J Perinatol"},{"key":"566_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10545-016-9936-y","volume":"39","author":"L Varela-Lema","year":"2016","unstructured":"Varela-Lema L, Paz-Valinas L, Atienza-Merino G, Zubizarreta-Alberdi R, Villares R, L\u00f3pez-Garc\u00eda M. Appropriateness of newborn screening for classic galactosaemia: a systematic review. J Inherit Metab Dis. 2016;39:633\u201349.","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"566_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/jp.2008.211","volume":"29","author":"L Johnson","year":"2009","unstructured":"Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol. 2009;29 Suppl 1:25\u201345.","journal-title":"J Perinatol"},{"key":"566_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcmd.2012.10.004","volume":"50","author":"RD Christensen","year":"2013","unstructured":"Christensen RD, Lambert DK, Henry E, Eggert LD, Yaish HM, Reading NS, et al. Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis. 2013;50:105\u20139.","journal-title":"Blood Cells Mol Dis"},{"key":"566_CR35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/jp.2014.68","volume":"34","author":"RD Christensen","year":"2014","unstructured":"Christensen RD, Nussenzveig RH, Yaish HM, Henry E, Eggert LD, Agarwal AM. Causes of hemolysis in neonates with extreme hyperbilirubinemia. J Perinatol. 2014;34:616\u20139.","journal-title":"J Perinatol"},{"key":"566_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcmd.2018.05.002","volume":"72","author":"RD Christensen","year":"2018","unstructured":"Christensen RD, Agarwal AM, George TI, Bhutani VK, Yaish HM. Acute neonatal bilirubin encephalopathy in the State of Utah 2009\u201318. Blood Cells Mol Dis. 2018;72:10\u201313.","journal-title":"Blood Cells Mol Dis"},{"key":"566_CR37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1651-2227.1997.tb08608.x","volume":"86","author":"T Hansen","year":"2008","unstructured":"Hansen T. Acute management of extreme neonatal jaundice-the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr. 2008;86:843\u20136.","journal-title":"Acta Paediatr"},{"key":"566_CR38","unstructured":"Danish Paediatric Society. Guideline for treatment of neonatal hyperbilirubinemia. 2012. http:\/\/www.paediatri.dk\/images\/pdf_filer\/dps_vejl\/neo\/008neo.pdf."},{"key":"566_CR39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0883073807309780","volume":"23","author":"S Katar","year":"2008","unstructured":"Katar S, Akay H, Taskesen M, Devecioglu C. Clinical and cranial magnetic resonance imaging (MRI) findings of 21 patients with serious hyperbilirubinemia. J Child Neurol. 2008;23:415\u20137.","journal-title":"J Child Neurol"},{"key":"566_CR40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2310\/7010.2001.7181","volume":"16","author":"Y Yilmaz","year":"2001","unstructured":"Yilmaz Y, Alper G, Kili\u00e7oglu G, Celik L, Karadeniz L, Yilmaz-Degirmenci S. Magnetic resonance imaging findings in patients with severe neonatal indirect hyperbilirubinemia. J Child Neurol. 2001;16:452\u20135.","journal-title":"J Child Neurol"},{"key":"566_CR41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1542\/peds.107.5.1075","volume":"107","author":"MC Harris","year":"2001","unstructured":"Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107:1075\u201380.","journal-title":"Pediatrics"},{"key":"566_CR42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.104.S6.1208","volume":"104","author":"L Johnson","year":"1999","unstructured":"Johnson L, Brown A, Bhutani V. BIND\u2014a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics. 1999;104:746\u20137.","journal-title":"Pediatrics"},{"key":"566_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpeds.2016.12.079","volume":"183","author":"S El Houchi","year":"2017","unstructured":"El Houchi S, Iskander I, Gamaleldin R, El Shenawy A, Seoud I, Abou-Youssef H, et al. Prediction of 3- to 5-Month outcomes from signs of acute bilirubin toxicity in newborn infants. J Pediatr. 2017;183:51\u20135.","journal-title":"J Pediatr"},{"key":"566_CR44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.jp.7211152","volume":"24","author":"V Bhutani","year":"2004","unstructured":"Bhutani V, Johnson L, Jeffrey Maisels M, Newman T, Phibbs C, Stark A, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24:650\u201362.","journal-title":"J Perinatol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0566-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:29:54Z","timestamp":1684618194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0566-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1038\/s41372-019-0566-8","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"7 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Danish Data Protection Agency, 2008-58-0028\/ 2016-71, and the Danish Health Authority, 3-3013-1624\/1.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}